PCMK
ABBV icon

Paragon Capital Management (Kansas)’s AbbVie ABBV Stock Holding History

Paragon Capital Management (Kansas)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Sell
1,099
-217
-16% -$46.7K 0.13% 52
2026
Q1 		$286K Buy
1,316
+429
+48% +$95.2K 0.14% 54
2025
Q4 		$203K Buy
+887
New +$202K 0.1% 59
2025
Q1 		– Sell
-1,260
Closed -$224K – 51
2024
Q4 		$224K Buy
1,260
+211
+20% +$38.8K 0.12% 51
2024
Q3 		$207K Buy
+1,049
New +$196K 0.11% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Paragon Capital Management (Kansas)'s ABBV Position: Q2 2026 in Review

Paragon Capital Management (Kansas) reduced its AbbVie (ABBV) stake by 16% in Q2 2026, selling an estimated $46.7K and leaving 1,099 shares worth $277K. The position accounts for 0.13% of the portfolio, ranked #52.

Paragon Capital Management (Kansas) first reported a position in ABBV in Q3 2024 and has held it in 5 quarters since. The position peaked at $286K in Q1 2026. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Paragon Capital Management (Kansas) held 1,099 shares of AbbVie worth $277K as of Q2 2026.
  • Paragon Capital Management (Kansas) sold 217 AbbVie shares in Q2 2026, an estimated $46.7K.
  • AbbVie made up 0.13% of Paragon Capital Management (Kansas)'s portfolio in Q2 2026, its #52 holding.
  • Paragon Capital Management (Kansas) first reported a position in AbbVie in Q3 2024 and has held it in 5 quarters since.
  • Paragon Capital Management (Kansas)'s AbbVie position peaked at $286K in Q1 2026.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q2 2026, filed 5 Aug 2026.